Form 4: Neuronetics EVP Sells Shares for Tax Obligations
Insider Transaction Report
Neuronetics' Executive Vice President, Chief Legal Officer, and Corporate Secretary, William Andrew Macan, sold 3,485 shares of common stock to cover tax withholding obligations related to a restricted stock unit vesting.
Summary
- William Andrew Macan, EVP, CLO and CS of Neuronetics, Inc. (STIM), disposed of 3,485 shares of common stock.
- The transaction occurred on February 10, 2026.
- The shares were sold at a weighted average price of $1.55 per share, with prices ranging from $1.45 to $1.60.
- The sale was non-discretionary and intended to satisfy tax withholding obligations upon the vesting of a restricted stock unit award.
- Following this transaction, Mr. Macan beneficially owns 687,681 shares of Neuronetics common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The transaction is a routine, non-discretionary sale for tax purposes, not indicative of a change in the executive's confidence or the company's fundamentals.
Industry Context
StockSavvy.ai notes that non-discretionary sales by executives to cover tax obligations upon the vesting of equity awards are a common and routine occurrence in the industry. These types of transactions typically do not reflect a change in management's sentiment regarding the company's future prospects or operational performance.
Stakeholder Impact
- Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in the executive's investment thesis or company outlook.
Key Dates
| Date | Description |
|---|---|
| 02/10/2026 | Date of transaction where 3,485 shares were sold. |
| 02/12/2026 | Date the Form 4 was filed with the SEC. |
Recommendation
holdThe transaction reported is a routine, non-discretionary sale by an executive to cover tax obligations associated with equity vesting. It does not provide new information that would alter the fundamental investment thesis for Neuronetics, Inc. Therefore, a 'hold' recommendation is appropriate as there's no new catalyst for a change in position based solely on this filing.
Keywords
Neuronetics, STIM, Insider Trading, Form 4, Executive Stock Sale, Restricted Stock Units, Tax Withholding, Corporate Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.